Safety and Pharmacokinetics of HU6
Clinical trial NCT05433506 · COMPLETED
Trial details
- NCT number
- NCT05433506
- Sponsor
- Rivus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2023-01-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.